Showing results (41-50 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|August 5, 2016
Associations between functional FCGR2A R131H and FCGR3A F158V polymorphisms and responsiveness to TNF blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysisYoung Ho Lee, Sung Jae Choi, Jong Dae Ji, et al.Pharmacogenomics|June 25, 2015
Metabolic side effects and pharmacogenetics of second-generation antipsychotics in childrenAngela M Devlin, Constadina PanagiotopoulosPharmacogenomics|July 28, 2016
Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirementAddepalli Pavani, Shaik Mohammad Naushad, Ganapathy Lakshmitha, et al.Pharmacogenomics|July 30, 2016
Cytochrome and sulfotransferase gene variation in north African populationsAna Fernández-Santander, Apolonia Novillo, María Gaibar, et al.Pharmacogenomics|July 30, 2016
Opioid treatment failure in cancer patients: the role of clinical and genetic factorsAstrid W Oosten, Maja Matic, Ron H van Schaik, et al.Pharmacogenomics|June 18, 2015
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemiaAjay Abraham, Savitha Varatharajan, Sreeja Karathedath, et al.Pharmacogenomics|June 19, 2015
URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemiaHong Sun, Qiang Qu, Jian Qu, et al.Pharmacogenomics|June 13, 2015
Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory diseasePedro Ayuso, María Del Carmen Plaza-Serón, Natalia Blanca-López, et al.Pharmacogenomics|March 27, 2018
Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patientsJanan Arslan, Paul N BairdPharmacogenomics|March 27, 2018
Are haplotypes in a single methotrexate pathway more predictive for response in rheumatoid arthritis than in different pathways?Tomas Soukup, Ivan Barvik, Jana Nekvindova, et al.Pageof 274